160 related articles for article (PubMed ID: 9002966)
41. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
42. Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping.
Oster W; König K; Ludwig WD; Ganser A; Lindemann A; Mertelsmann R; Herrmann F
Leuk Res; 1988; 12(11-12):887-95. PubMed ID: 2851073
[TBL] [Abstract][Full Text] [Related]
43. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
44. Analysis of acute myeloid leukemia cells by flow cytometry, introducing a new light-scattering classification.
Harada N; Okamura S; Kubota A; Shimoda K; Ikematsu W; Kondo S; Harada M; Niho Y
J Cancer Res Clin Oncol; 1994; 120(9):553-7. PubMed ID: 8045921
[TBL] [Abstract][Full Text] [Related]
45. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia.
Tisone JA; Bohman JE; Theil KS; Brandt JT
Am J Clin Pathol; 1997 Mar; 107(3):283-91. PubMed ID: 9052378
[TBL] [Abstract][Full Text] [Related]
47. Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years.
Huang SY; Tang JL; Jou ST; Tsay W; Hu CH; Lin DT; Lin KS; Lin KS; Wang CH; Chen YC; Shen MC; Tien HF
Leukemia; 1999 Oct; 13(10):1506-12. PubMed ID: 10516750
[TBL] [Abstract][Full Text] [Related]
48. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
[TBL] [Abstract][Full Text] [Related]
49. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases.
Venditti A; Del Poeta G; Stasi R; Masi M; Bruno A; Buccisano F; Cox C; Coppetelli U; Aronica G; Simone MD
Br J Haematol; 1994 Dec; 88(4):784-93. PubMed ID: 7819103
[TBL] [Abstract][Full Text] [Related]
50. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
[TBL] [Abstract][Full Text] [Related]
51. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
[TBL] [Abstract][Full Text] [Related]
52. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
54. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.
Neame PB; Soamboonsrup P; Browman GP; Meyer RM; Benger A; Wilson WE; Walker IR; Saeed N; McBride JA
Blood; 1986 Dec; 68(6):1355-62. PubMed ID: 3465377
[TBL] [Abstract][Full Text] [Related]
55. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
[TBL] [Abstract][Full Text] [Related]
56. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
57. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
58. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
59. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
[TBL] [Abstract][Full Text] [Related]
60. Lymphoid-associated antigen expression by acute myeloid leukemia.
Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
